Back to top
more

Foundation Medicine, Inc. (FMI)

(Real Time Quote from BATS)

$137.00 USD

137.00
NA

-0.05 (-0.04%)

Updated Jul 31, 2018 03:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[FMI]

Reports for Purchase

Showing records 1 - 20 ( 41 total )

Industry: Medical Info Systems

Record: 1

10/07/2016

Industry Report

Pages: 11

Sector Analysis Update: Molecular Diagnostics: Does the Turnaround have ''''Legs''''?

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: GRISEWOOD S

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 2

10/07/2016

Company Report

Pages: 4

Dropping Coverage Due to Analyst Departure

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 3

12/14/2015

Daily Note

Pages: 37

Equity Research - Our Most Non-Consensus Stock Picks for 2016

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 4

11/04/2015

Company Report

Pages: 11

3Q15 Recap - Top-line Better But Clinical Volume - Guidance Very Weak - Lowering Street Low 2016 Estimates

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 5

10/27/2015

Company Report

Pages: 9

Expecting In-line 3Q15 Sales - Business Remains Complicated - 2016 Forecasts Too High - Maintain N

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 6

09/16/2015

Daily Note

Pages: 8

Investor Day Recap - No Surprises - ctDNA Test on Track - Reimbursement Comments Ok - GeneKit Interesting - Consensus 2016 Still a Concern- Maintain N

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 7

09/16/2015

Daily Note

Pages: 8

Investor Day Recap - No Surprises - ctDNA Test on Track - Reimbursement Comments Ok - GeneKit Interesting - Consensus 2016 Still a Concern- Maintain N

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 8

07/30/2015

Company Report

Pages: 11

2Q15 Top-line - Guidance Disappoints Meaningfully - Trimming Our Street Low View Further - Cutting PT from $41 to $26 Due to the Competitive Specter

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 9

07/24/2015

Industry Report

Pages: 6

The Week Ahead in Life Sciences - Upcoming Events for the Week of July 27

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 10

05/12/2015

Company Report

Pages: 11

1Q15 Recap - Clinical Volume Soft Again - Pharma Better - Pipeline On Track - Volume Guidance Looks Unrealistic - Lowering PT to $41 - Maintain N

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 11

05/08/2015

Industry Report

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of May 11th

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 12

05/04/2015

Company Report

Pages: 9

1Q15 Preview - Expecting Roughly In-line Results - Mid- Quarter Oncology Checks Ok - Maintain NEUTRAL

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 13

02/25/2015

Company Report

Pages: 11

4Q14 Results In-Line with Preannouncement - Downgrading to NEUTRAL from OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 14

02/23/2015

Company Report

Pages: 9

4Q14 Preview - Expecting In-line 4Q Results Following Preliminaries - Split Between Clinical - Pharma Services - Pipeline In Focus - Maintain OP

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 15

01/12/2015

Company Report

Pages: 9

Roche Buying Majority Stake in FMI at $50/sh - Investing $250 MM - Positive Top-Line Preannouncement - Model Under Review - PT to $45 - Maintain OP

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 16

11/24/2014

Daily Note

Pages: 5

LIFE SCIENCES AND HEALTH CARE

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 17

11/17/2014

Industry Report

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov 17

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 18

11/06/2014

Company Report

Pages: 12

3Q14 Clinical Volume Soft as Strong Pharma Drives Beat & Raise - Struggling Over Testing Frequency - Reducing Estimates - PT to $35 - Maintain OP

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 19

11/03/2014

Company Report

Pages: 9

Expecting In-line 3Q14 Financials with Healthy Volumes & Improving Reimbursement

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 20

09/24/2014

Company Report

Pages: 8

Opportunity Slightly Murkier Post Doc Calls - Reimbursement & Competition Dynamics Fine - Lowering

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party
// eof